GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Argyle Capital Management LLC

Argyle Capital Management LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 32.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,782 shares of the company’s stock after purchasing an additional 3,838 shares during the quarter. Argyle Capital Management LLC’s holdings in GE HealthCare Technologies were worth $1,234,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Assenagon Asset Management S.A. raised its holdings in GE HealthCare Technologies by 10.1% in the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock valued at $1,289,000 after buying an additional 1,256 shares during the period. Nisa Investment Advisors LLC increased its position in shares of GE HealthCare Technologies by 2.6% during the third quarter. Nisa Investment Advisors LLC now owns 76,349 shares of the company’s stock valued at $7,165,000 after acquiring an additional 1,920 shares during the last quarter. Valmark Advisers Inc. purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $222,000. Golden State Equity Partners acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $532,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $221,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $89.40 on Friday. The business’s 50-day moving average is $86.00 and its two-hundred day moving average is $86.07. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The firm has a market capitalization of $40.88 billion, a P/E ratio of 20.65, a P/E/G ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analysts Set New Price Targets

GEHC has been the topic of a number of research analyst reports. Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.